Profile data is unavailable for this security.
About the company
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
- Revenue in JPY (TTM)1.60tn
- Net income in JPY200.73bn
- Incorporated2005
- Employees18.73k
- LocationDaiichi Sankyo Co LtdDaiichi Sankyo Bldg. A/B Kan3-5-1, Nihombashi Hon-choCHUO-KU 103-8426JapanJPN
- Phone+81 362251111
- Websitehttps://www.daiichisankyo.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon PLC | 2.29tn | 221.19bn | 6.06tn | 24.00k | 27.79 | -- | 157.73 | 2.64 | 0.1168 | 0.1168 | 1.21 | -- | -- | -- | -- | 468,125.00 | -- | -- | -- | -- | 61.71 | -- | 10.12 | -- | -- | 7.27 | -- | -- | 4.09 | -- | -1.04 | -- | -- | -- |
| Takeda Pharmaceutical Co Ltd | 4.26tn | 144.07bn | 6.63tn | 49.28k | 45.96 | 0.9043 | 7.61 | 1.56 | 91.21 | 91.21 | 2,714.06 | 4,635.56 | 0.2934 | 1.30 | 7.18 | 86,519,390.00 | 0.9922 | 1.65 | 1.19 | 1.97 | 66.54 | 68.05 | 3.38 | 6.06 | 0.5831 | 2.40 | 0.3997 | 128.42 | 5.87 | 15.25 | -54.56 | 1.28 | 29.09 | 0.8735 |
| Sun Pharmaceutical Industries Ltd | 938.18bn | 185.26bn | 7.06tn | 41.00k | 38.12 | 5.73 | 29.90 | 7.52 | 39.90 | 39.90 | 202.02 | 265.35 | 0.5836 | 1.05 | 4.28 | -- | 11.61 | 7.77 | 15.75 | 10.85 | 78.01 | 72.30 | 19.89 | 14.23 | 1.98 | 51.55 | 0.0465 | 39.86 | 10.51 | 10.78 | 13.01 | 29.15 | -7.28 | 37.47 |
| Chugai Pharmaceutical Co Ltd | 1.04tn | 326.37bn | 9.48tn | 7.60k | 28.48 | 5.66 | -- | 9.15 | 198.34 | 198.34 | 629.63 | 997.97 | 0.5647 | 1.21 | 3.45 | 136,254,000.00 | 17.79 | 19.29 | 20.95 | 23.91 | 67.67 | 63.57 | 31.50 | 28.39 | 4.37 | -- | 0.00 | 40.14 | -11.78 | 13.90 | -13.08 | 28.61 | -0.8947 | 27.23 |
| Daiichi Sankyo Co Ltd | 1.60tn | 200.73bn | 10.57tn | 18.73k | 51.87 | 6.16 | 40.54 | 6.60 | 104.62 | 104.62 | 834.79 | 880.40 | 0.5366 | 1.12 | 3.99 | 85,532,790.00 | 6.73 | 4.99 | 8.53 | 6.14 | 74.07 | 69.10 | 12.55 | 9.94 | 2.40 | -- | 0.0846 | 51.87 | 25.28 | 11.49 | 85.90 | 16.67 | 13.01 | 16.47 |
| Merck KGaA | 3.61tn | 472.20bn | 11.46tn | 62.35k | 24.27 | 2.36 | 14.62 | 3.18 | 6.27 | 6.27 | 47.90 | 64.39 | 0.4243 | 1.82 | 4.81 | 330,959.50 | 5.57 | 5.64 | 6.96 | 7.27 | 58.03 | 61.86 | 13.13 | 12.97 | 0.8157 | 29.56 | 0.261 | 9.26 | -5.57 | 7.19 | -15.09 | 21.40 | 14.77 | 11.97 |
| Zoetis Inc | 1.41tn | 386.06bn | 12.71tn | 14.10k | 33.27 | 15.59 | 27.30 | 9.02 | 5.19 | 5.19 | 18.95 | 11.07 | 0.6216 | 1.00 | 7.05 | 619,432.60 | 17.00 | 14.47 | 19.66 | 17.18 | 70.13 | 69.80 | 27.34 | 25.77 | 1.94 | 16.82 | 0.5659 | 26.89 | 5.74 | 7.96 | 10.88 | 11.13 | 16.71 | 24.37 |
| GSK plc | 6.28tn | 915.79bn | 12.92tn | 70.21k | 13.98 | 4.57 | 9.09 | 2.06 | 1.09 | 1.09 | 7.48 | 3.34 | 0.525 | 1.51 | 4.50 | 437,816.90 | 8.13 | 6.74 | 12.25 | 10.71 | 72.76 | 70.29 | 15.48 | 16.93 | 0.5796 | 11.37 | 0.5733 | 79.55 | 3.42 | -0.322 | 15.79 | 7.10 | 5.47 | -10.32 |
| Bristol-Myers Squibb Co | 7.35tn | -992.69bn | 13.52tn | 34.10k | -- | 5.08 | 22.46 | 1.84 | -3.10 | -3.10 | 22.15 | 8.14 | 0.4711 | 3.92 | 5.18 | 1,335,308.00 | -6.35 | 3.05 | -8.27 | 3.76 | 75.94 | 76.13 | -13.47 | 7.69 | 0.9947 | 15.54 | 0.7709 | 133.63 | -2.50 | 14.81 | 26.84 | 10.03 | 4.92 | 7.34 |
| Gilead Sciences, Inc. | 4.43tn | 78.15bn | 13.81tn | 18.00k | 190.88 | 4.88 | 26.71 | 3.12 | 0.3596 | 0.3596 | 21.89 | 14.08 | 0.4646 | 3.60 | 6.22 | 1,525,000.00 | 0.7718 | 6.74 | 0.9624 | 8.12 | 77.52 | 79.14 | 1.66 | 16.95 | 0.9365 | 15.25 | 0.5907 | 81.22 | -0.6048 | 4.15 | 23.37 | 0.7436 | -8.74 | 5.64 |
Data as of Jul 03 2024. Currency figures normalised to Daiichi Sankyo Co Ltd's reporting currency: Japanese Yen JPY
28.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital International Ltd.as of 06 Jun 2024 | 105.20m | 5.40% |
| Nomura Asset Management Co., Ltd.as of 31 May 2024 | 88.05m | 4.52% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 68.98m | 3.54% |
| Wellington Management Co. LLPas of 31 May 2024 | 60.89m | 3.13% |
| Asset Management One Co., Ltd.as of 15 Mar 2024 | 55.62m | 2.86% |
| Nikko Asset Management Co., Ltd.as of 07 Jun 2024 | 41.19m | 2.12% |
| Daiwa Asset Management Co. Ltd.as of 31 May 2024 | 39.76m | 2.04% |
| BlackRock Fund Advisorsas of 06 Jun 2024 | 37.19m | 1.91% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 32.63m | 1.68% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 2024 | 22.64m | 1.16% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
